Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06069349Not ApplicableUnknown

Timing of Mobilization on Delirium in Patients After Cardiac Surgery

Role: lead

NCT03341572Not ApplicableUnknown

The Effect of Positive End Expiratory Pressure on Central Venous Pressure Among Patients With Different Lung Compliance

Role: lead

NCT03340649Unknown

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis

Role: lead

NCT03296761Unknown

Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury

Role: lead

All 4 trials loaded